Neuropilin-1 drives SARS-CoV-2 infectivity, finds breakthrough study

Researchers have potentially identified what makes SARS-CoV-2 highly infectious and able to spread rapidly in human cells. The findings describe how the virus’s ability to infect human cells can be reduced by inhibitors that block a newly discovered interaction between virus and host, demonstrating a potential anti-viral treatment.